Yesil E, Toprak Z, Sit D, Kayabasi H

Language: English
References: 30
Page: 87-95
PDF size: 211.57 Kb.

ABSTRACT

Background: In addition to diabetic nephropathies (DNP), prevalence of nondiabetic nephropathies (NDNP) is also known to be frequent in patients diagnosed with type 2 Diabetes mellitus (DM). Early diagnosis of these conditions is important for the treatment and prognosis of these patients. Aim: This study aimed to investigate the relationships between clinical and laboratory findings of type 2 diabetic patients’ renal biopsies. Material and Methods: We retrospectively reviewed the medical records of 140 patients who had diagnosis of type 2 DM and underwent renal biopsy from July 2020- August 2022 at nephrology clinics of Hospital Umraniye. Renal biopsy results, presence of hypertension, diabetic retinopathy, hematuria, proteinuria; duration of the disease, biopsy indications, glycated hemoglobin (HbA1c), serum creatinine, blood urea nitrogen, albumin, and proteinuria levels in 24h urine were measured. The statistical significance level was determined as p‹0,05. Results: NDNP were detected in 43,7% of the patients. Among these the most common diagnosis was interstitial nephritis (20%). The most common biopsy indication was found to be nephrotic range proteinuria (30,7%). The difference between the DNP and NDNP patients’ renal biopsy indications was statistically significant (p‹0,001). DNP patients had a higher retinopathy incidence (60%,11%, p‹0,001). A statistically significant difference was detected between the disease duration of DNP and NDNP groups (11,23 +5,74 years, p:0,002). According to multivariate regression analysis DR and HbA1c value, more than 7% have 4, 482 and 4,591-fold increased the risk of DNP incidence (p=0,021, p:0,024). Conclusion: Early diagnosis of DNP and NDNP of diabetic patients by performing renal biopsies affects the treatment and prognosis of the patients. Therefore, when evaluating diabetic patients, its necessary not to overlook the findings suggestive of NDNP.

REFERENCES

1. Ritz E, Zeng X, Rychlik I. Clinical manifestationsand natural history of diabetic nephropathy. ContribNephrol. 2011:170;19-27.

2. Wagrowska-Danilewitz M, Danilewitz M. Spectrumof biopsy-proven renal disease in patients with type 2diabetes mellitus: a single center study. Pol J Pathol.2015;66(4):361-367.

3. Sharma SG, Bomback AS, Radhakrishnan J, Herlitz LC,Stokes MB, Markowitz GS, D’Agati VD. The modernspectrum of renal biopsy findings in patients withdiabetes. Clin J Am Soc Nephrol. 2013 Oct;8(10):1718-1724.

4. Pham TT, Sim JJ, Kujubu DA, Liu IL, Kumar VA.Prevalence of nondiabetic renal disease in diabeticpatients. Am J Nephrol. 2007;27(3):322-328

5. Byun JM, Lee CH, Lee SR, Moon JY, Lee SH, LeeTW, et al. . Renal outcomes and clinical course of nondiabeticrenal diseases in patients with type 2 diabetes.Korean j Intern Med.2013; 28:565-572.

6. Arif M, Arif MK, Arif MS. An evaluation of renalbiopsy in type 2 diabetic patients. J Coll Physicians SurgPak. 2009;19(10):627-631.

7. American Diabetes Association. Classification anddiagnosis of diabetes. Diabetes Care 2015;38: S8-16.

8. Alicic RZ, Rooney MT, Tuttle KR. Diabetic KidneyDisease: Challenges, Progress, and Possibilities. Clin JAm Soc Nephrol. 2017 Dec 7;12(12):2032-2045.

9. Tervaert TW, Mooyaart AL, Amann K, et al. . RenalPathology Society. Pathologic classification of diabeticnephropathy. J Am Soc Nephrol. 2010 Apr;21(4):556-563.

10. Unger T, Borghi C, Cahrchar F, Khan NA, PoulterNR, Prabhakaran D et al. . 2020 International Societyof Hypertension Global Hypertension Practiceguidelines. Hypertension 2020; 75:1334-1357.

11. Liu S, Guo Q, Han H, Cui P, Liu X, Miao L,et al. . Clinicopathological characteristics of nondiabeticrenal disease in patients with type 2 diabetesmellitus in a northeastern Chinese medical center: aretrospective analysis of 273 cases. Int Urol Nephrol.2016 ;48(10):1691-1698.

12. Imtiaz S, Salman B, Nasir K, Drohlia MF, AhmadA. Clinical variables differentiating diabetic fromnondiabetic kidney disease in patients with diabetes: Asingle-center study. Saudi J Kidney Dis Transpl. 2017;28(2):307-312.

13. Artan, A. S., Gürsu, M., Çoban, G., Elçioğlu, Ö.C., & Kazancıoğlu, R. Renal Biopsy in Patients withDiabetes: Indications, Results, and Clinical Predictorsof Diabetic Kidney Disease. Turkish journal ofnephrology.2021; 30(1), 2-8.

14. Heybeli, C., Oktan, M. A., Arda, H. U., Yildiz,S., Unlu, M., Demir T., et al. . Predictors andhistopathological characteristics of non‐diabetic renaldisorders in diabetes: a look from the tubulointerstitialpoint of view. Internal Medicine Journal.2019; 49(12), 1524-1533.

15. Wilfred DC, Mysorekar VV, Venkataramana RS,Eshwarappa M, Subramanyan R. Nondiabetic RenalDisease in type 2 Diabetes Mellitus Patients: AClinicopathological Study. J Lab Physicians. 2013;5(2): 94-99.

16. Yang L, Feng L, Huang Y, Xia N. A different diagnosismodel for diabetic nephropathy and non-diabetic renaldisease in patients with type 2 diabetes complicatedwith chronic kidney disease. Diabetes Metab Syndr Obes2019; 12:1963-1972.

17. He F, Xia X, Wu XF, Yu XQ, Huang FX. Diabeticretinopathy in predicting diabetic nephropathy inpatients with type 2 diabetes and renal disease: a metaanalysis.Diabetologia.2013;56:457-466.

18. Zhang J, Wang Y, Li L, Zhang R, Guo R, Li Het al. . Diabetic retinopathy may predict the renaloutcomes of patients with diabetic nephropathy. Renalfailure.2018;40:243-251.

19. García-Martín F, González Monte E, HernándezMartínez E, Bada Boch T, Bustamante Jiménez NE,Praga Terente M. When to perform renal biopsy inpatients with type2 diabetes mellitus? Predictive modelof non-diabetic renal disease. Nefrologia (Engl Ed). 2020; 40(2):180-189.

20. Prakash J, Lodha M, Singh SK, Vohra R, Raja R,Usha. Diabetic retinopathy is a poor predictor ofnephropathy in proteinuric type 2 diabetic patients. JAssoc Physicians India. 2007; 55:412-416.

21. Horvatic I, Tisljar M, Kacinari P, Matesic I,Bulimbasic S, Galesic Ljubanovic D, et al. . non-diabeticrenal disease in Croatian patients with type 2 diabetesmellitus. Diabetes Res Clin Pract. 2014;104(3):443-450.

22. Soni SS, Gowrishankar S, Kishan AG, Raman A.Non diabetic renal disease in type 2 diabetes mellitus.Nephrology (Carlton). 2006;11(6):533-537.

23. Bermejo S, Soler MJ, Gimeno J, Barrios C, RodríguezE, Mojal S, et al. . Predictive factors for non-diabeticnephropathy in diabetic patients. The utility of renalbiopsy. Nefrologia. 2016;36(5):535-544.

24. Liang S, Zhang XG, Cai GY, Zhu HY, Zhou JH, WuJ.,et al. . Identifying parameters to distinguish nondiabeticrenal diseases from diabetic nephropathy inpatients with type 2 diabetes mellitus: a meta-analysis.PLoS One. 2013 May 14;8(5): e64184.

25. Mak SK, Gwi E, Chan KW, Wong PN, Lo KY, LeeKF, et al. . Clinical predictors of non-diabetic renaldisease in patients with non-insulin-dependent diabetesmellitus. Nephrol Dial Transplant 1997; 12:2588-2591.

26. Matias, P., Viana, H., Carvalho, F., & Ribeiro Santos,J. Diabetes mellitus and renal disease: when to performa renal biopsy? Revista Portuguesa de Nefrologia eHipertensão,2009:167-173.

27. Serra A, Romero R, Bayés, B., Lopez D, Bonet J.Is there a need for changes in renal biopsy criteria inproteinuria in type 2 diabetes? Diabetes Res Clin Pract2002; 58:149-153.

28. Tone A, Shikata K, Matsuda M, Usui H, Okada S,Ogawa D et al. . Clinical features of non-diabetic renaldiseases in patients with type 2 diabetes. Diabetes ResClin Pract 2005; 69:237-242.

29. Lin Y.L., Peng S.J., Ferng S.H., Tzen C.Y., Yang C.S.Clinical indicators which necessitate renal biopsy intype 2 Diabetes Mellitus patients with renal disease. IntJ Clin Pract 2009; 63:1167-1176.

30. Yaqup S., Kashif W., Hussian S.A. Non-diabetic renaldisease in patients with type 2 diabetes mellitus. Saudi JKidney Dis Transpl. 2012; 23: 1000-1007.